EUVIMEDEUVIMED entdecken
Open Access

Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India

Avika Dixit, Yasha Ektefaie, Anju Kagal, Luca Freschi, Rajesh Karyakarte, Rahul Lokhande, Matthias Groschel, Jeffrey A Tornheim, Nikhil Gupte, Neeta N Pradhan, Mandar S Paradkar, Sona Deshmukh und 7 weitere

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiae240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Avika Dixit und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Drug Resistance, Multiple, Bacterial, Tuberculosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, US Civilian Research and Development Foundation (CRDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drivers of tuberculosis (TB) transmission in India, the country estimated to carry a quarter of the world's burden, are not well studied. We conducted a genomic epidemiology study to compare epidemiological success, host factors, and drug resistance among the 4 major Mycobacterium tuberculosis (Mtb) lineages (L1–L4) circulating in Pune, India.

Methods

We performed whole-genome sequencing (WGS) of Mtb sputum culture–positive isolates from participants in two prospective cohort studies and predicted genotypic susceptibility using a validated random forest model. We compared lineage-specific phylogenetic and time-scaled metrics to assess epidemiological success.

Results

Of the 612 isolates that met sequence quality criteria, Most were L3 (44.6%). The majority (61.1%) of multidrug-resistant isolates were L2 (P < .001) and L2 demonstrated a higher rate and more recent resistance acquisition. L4 and/or L2 demonstrated higher clustering and time-scaled haplotypic density (THD) compared to L3 and/or L1, suggesting higher epidemiological success. L4 demonstrated higher THD and clustering (odds ratio, 5.1 [95% confidence interval, 2.3–12.3]) in multivariate models controlling for host factors and resistance.

Conclusions

L2 shows a higher frequency of resistance, and both L2 and L4 demonstrate evidence of higher epidemiological success than L3 or L1 in Pune. Contact tracing around TB cases and heightened surveillance of TB DR in India is a public health priority.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantDrug Resistance, Multiple, BacterialTuberculosisHumansIndiaMaleAdultProspective StudiesFemaleWhole Genome SequencingAntitubercular AgentsMiddle AgedPhylogenyGenotypeYoung AdultSputumMolecular Epidemiology

Stichwörter der Autor:innen

drug resistancelineagetransmissiontuberculosiswhole-genome sequencing

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
  • Byramjee-Jeejeebhoy Government Medical College, Pune, India.
  • Center for Clinical Global Health Education, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Byramjee-Jeejeebhoy Medical College-Johns Hopkins University Clinical Trials Unit, Pune, India.

ORCID-Profile: Amita Gupta, Vidya Mave, Maha Farhat

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • US Civilian Research and Development Foundation (CRDF)
  • NHGRI NIH HHS
  • German Research Foundation
  • Indo-US Medical Partnership
  • BTREC
  • Boston Children's Hospital OFD

Zitieren

APA

Dixit, A., Ektefaie, Y., Kagal, A., Freschi, L., Karyakarte, R., Lokhande, R., Groschel, M., Tornheim, J. A., Gupte, N., Pradhan, N. N., Paradkar, M. S., Deshmukh, S., Kadam, D., Schito, M., Engelthaler, D. M., Gupta, A., Golub, J., Mave, V., & Farhat, M. (2025). Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae240

Vancouver

Dixit A, Ektefaie Y, Kagal A, Freschi L, Karyakarte R, Lokhande R, et al. Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae240

BibTeX
@article{Dixit2025,
  author = {Dixit, Avika and Ektefaie, Yasha and Kagal, Anju and Freschi, Luca and Karyakarte, Rajesh and Lokhande, Rahul and Groschel, Matthias and Tornheim, Jeffrey A and Gupte, Nikhil and Pradhan, Neeta N and Paradkar, Mandar S and Deshmukh, Sona and Kadam, Dileep and Schito, Marco and Engelthaler, David M and Gupta, Amita and Golub, Jonathan and Mave, Vidya and Farhat, Maha},
  title = {Drug Resistance and Epidemiological Success of Modern Mycobacterium tuberculosis Lineages in Western India},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiae240}
}
Kostenlos starten →